Advertisement

Vitamin D status and cardiovascular outcome

  • F. SaponaroEmail author
  • C. Marcocci
  • R. Zucchi
Short Review
  • 38 Downloads

Abstract

Introduction

Vitamin D is classically involved in maintaining bone and mineral health, but it has been shown to exert many extraskeletal functions, including pleiotropic effects on cardiovascular system.

Materials and method

This review aims to summarize evidences in literature about vitamin D and cardiovascular outcome.

Results and conclusions

Calcitriol or 1,25(OH)2D, the active hormone, binds to the specific nuclear receptor VDR, which is expressed in rat and human heart and vasculature and has effects on myocardiocytes, smooth cells, and endothelial cells. 25-Hydroxy-vitamin D (25OHD) represents the biomarker of vitamin D levels and reflects vitamin D status. There is consistent evidence that low serum 25OHD levels are associated with increased risk of cardiovascular diseases, including hypertension, coronary artery disease, ischemic heart disease, heart failure, stroke, and type 2 diabetes. Randomized-controlled trials and Mendelian randomization studies so far have not succeeded in proving a benefit of vitamin D supplementation. However, the latter investigations are affected by some methodological limitations, and therefore, it is still unclear if vitamin D deficiency has a causative role in cardiovascular diseases or is rather a marker of poor health in chronic disease.

Keywords

Vitamin D Calcitriol Cardiovascular risk Heart failure 

Notes

Funding

No funding.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This manuscript is a review of the literature and does not contain original research either on animal or on human subjects.

Informed consent

For this type of manuscript, informed consent is not required.

References

  1. 1.
    Li YC, Kong J, Wei M et al (2002) 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin–angiotensin system. J Clin Invest 110:229–238.  https://doi.org/10.1172/JCI200215219 CrossRefGoogle Scholar
  2. 2.
    Li YC (2003) Vitamin D regulation of the renin–angiotensin system. J Cell Biochem 88:327–331CrossRefGoogle Scholar
  3. 3.
    Rahman A, Hershey S, Ahmed S et al (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103:416–419.  https://doi.org/10.1016/j.jsbmb.2006.12.081 CrossRefGoogle Scholar
  4. 4.
    Schleithoff SS, Zittermann A, Tenderich G et al (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754–759CrossRefGoogle Scholar
  5. 5.
    Wimalawansa SJ (2018) Vitamin D and cardiovascular diseases: causality. J Steroid Biochem Mol Biol 175:29–43.  https://doi.org/10.1016/j.jsbmb.2016.12.016 CrossRefGoogle Scholar
  6. 6.
    Skaaby T, Husemoen LLN, Pisinger C et al (2013) Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43:618–625.  https://doi.org/10.1007/s12020-012-9805-x CrossRefGoogle Scholar
  7. 7.
    Wang L, Song Y, Manson JE et al (2012) Circulating levels of 25Hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5:819–829.  https://doi.org/10.1161/CIRCOUTCOMES.112.967604.Circulating CrossRefGoogle Scholar
  8. 8.
    Lugg ST, Howells PA, Thickett DR (2015) Optimal Vitamin D supplementation levels for cardiovascular disease protection. Dis Mark.  https://doi.org/10.1155/2015/864370 Google Scholar
  9. 9.
    Judd SE, Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338:40–44.  https://doi.org/10.1097/MAJ.0b013e3181aaee91 CrossRefGoogle Scholar
  10. 10.
    Kestenbaum B, Katz R, De Boer I et al (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. JAC 58:1433–1441.  https://doi.org/10.1016/j.jacc.2011.03.069 Google Scholar
  11. 11.
    Muscogiuri G, Nuzzo V, Gatti A et al (2015) Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? Endocrine.  https://doi.org/10.1007/s12020-015-0609-7 Google Scholar
  12. 12.
    Scragg R (1981) Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 10:337–341CrossRefGoogle Scholar
  13. 13.
    Wang TJ (2016) Vitamin D and cardiovascular disease. Annu Rev Med 67:261–272.  https://doi.org/10.1146/annurev-med-051214-025146 CrossRefGoogle Scholar
  14. 14.
    Wu-Wong JR, Nakane M, Ma J et al (2006) Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 186:20–28.  https://doi.org/10.1016/j.atherosclerosis.2005.06.046 CrossRefGoogle Scholar
  15. 15.
    Andrukhova O, Slavic S, Zeitz U et al (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol.  https://doi.org/10.1210/me.2013-1252 Google Scholar
  16. 16.
    Wong MSK, Delansorne R, Man RYK, Vanhoutte PM (2008) Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. AJP Hear Circ Physiol.  https://doi.org/10.1152/ajpheart.00116.2008 Google Scholar
  17. 17.
    Hirata M, Serizawa KI, Aizawa K et al (2013) 22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy. Nephrol Dial Transplant.  https://doi.org/10.1093/ndt/gfs536 Google Scholar
  18. 18.
    Yuan W, Pan W, Kong J et al (2007) 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem.  https://doi.org/10.1074/jbc.M705495200 Google Scholar
  19. 19.
    Aihara KI, Azuma H, Akaike M et al (2004) Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279:35798–35802.  https://doi.org/10.1074/jbc.M404865200 CrossRefGoogle Scholar
  20. 20.
    Harvey NC, Cantorna MT (2013) Vitamin D and the immune system. Diet Immun Inflamm.  https://doi.org/10.1533/9780857095749.2.244 Google Scholar
  21. 21.
    Cipriani C, Pepe J, Colangelo L, Minisola S (2018) Vitamin D and secondary hyperparathyroid states. Front Horm Res 50:138–148.  https://doi.org/10.1159/000486077 CrossRefGoogle Scholar
  22. 22.
    Yu N, Donnan PT, Flynn RWV et al (2010) Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf).  https://doi.org/10.1111/j.1365-2265.2009.03766.x Google Scholar
  23. 23.
    Pepe J, Diacinti D, Fratini E et al (2016) High prevalence of abdominal aortic calcification in patients with primary hyperparathyroidism as evaluated by Kauppila score. Eur J Endocrinol.  https://doi.org/10.1530/EJE-15-1152 Google Scholar
  24. 24.
    Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511.  https://doi.org/10.1161/CIRCULATIONAHA.107.706127 CrossRefGoogle Scholar
  25. 25.
    Fiscella K, Franks P (2010) Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 8:11–18.  https://doi.org/10.1370/afm.1035.2 CrossRefGoogle Scholar
  26. 26.
    Al-Khalidi B, Kimball SM, Rotondi MA, Ardern CI (2017) Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in US adults: a cross-sectional analysis of NHANES, 2001–2010. Nutr J.  https://doi.org/10.1186/s12937-017-0237-6 Google Scholar
  27. 27.
    Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG (2012) 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol.  https://doi.org/10.1161/ATVBAHA.112.248039 Google Scholar
  28. 28.
    Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174–1180.  https://doi.org/10.1001/archinte.168.11.1174 CrossRefGoogle Scholar
  29. 29.
    Kilkkinen A, Knekt P, Aro A et al (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170:1032–1039.  https://doi.org/10.1093/aje/kwp227 CrossRefGoogle Scholar
  30. 30.
    Giovinazzo S, Alibrandi A, Campennì A et al (2017) Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women. J Endocrinol Invest 40:1337–1343.  https://doi.org/10.1007/s40618-017-0707-x CrossRefGoogle Scholar
  31. 31.
    Vanlint S (2013) Vitamin D and obesity. Nutrients.  https://doi.org/10.3390/nu5030949 Google Scholar
  32. 32.
    Wortsman J, Matsuoka LY, Chen TC et al (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690CrossRefGoogle Scholar
  33. 33.
    Cipriani C, Pepe J, Piemonte S et al (2014) Vitamin D and its relationship with obesity and muscle. Int J Endocrinol.  https://doi.org/10.1155/2014/841248 Google Scholar
  34. 34.
    Lương KVQ, Nguyễn LTH (2013) The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr J.  https://doi.org/10.1186/1475-2891-12-89 Google Scholar
  35. 35.
    Gotsman I, Shauer A, Zwas DR et al (2012) Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; Vitamin D supplementation improves outcome. Eur J Heart Fail 14:357–366.  https://doi.org/10.1093/eurjhf/hfr175 CrossRefGoogle Scholar
  36. 36.
    Saponaro F, Marcocci C, Zucchi R et al (2017) Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival. Endocrine.  https://doi.org/10.1007/s12020-017-1282-9 Google Scholar
  37. 37.
    Saponaro F, Saba A, Frascarelli S et al (2018) Vitamin D measurement and effect on outcome in a cohort of patients with heart failure. Endocr Connect.  https://doi.org/10.1530/EC-18-0207 Google Scholar
  38. 38.
    Autier P, Boniol M, Pizot C, Mullie P (2014) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol.  https://doi.org/10.1016/S2213-8587(13)70165-7 Google Scholar
  39. 39.
    Tomson J, Emberson J, Hill M et al (2013) Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur Heart J.  https://doi.org/10.1093/eurheartj/ehs426 Google Scholar
  40. 40.
    Zhou R, Wang M, Huang H et al (2018) Lower vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients.  https://doi.org/10.3390/nu10030277 Google Scholar
  41. 41.
    Zhang R, Li B, Gao X et al (2017) Serum 25-hydroxyVitamin D and the risk of cardiovascular disease: dose–response meta-analysis of prospective studies 1–3. Am J Clin Nutr.  https://doi.org/10.3945/ajcn.116.140392 Google Scholar
  42. 42.
    Gaksch M, Jorde R, Grimnes G et al (2017) Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS ONE.  https://doi.org/10.1371/journal.pone.0170791 Google Scholar
  43. 43.
    Hsia J, Heiss G, Ren H et al (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115:846–854.  https://doi.org/10.1161/CIRCULATIONAHA.106.673491 CrossRefGoogle Scholar
  44. 44.
    Bolland MJ, Grey A, Avenell A et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ.  https://doi.org/10.1136/bmj.d2040 Google Scholar
  45. 45.
    Bjelakovic G, Gluud LL, Nikolova D et al (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470Google Scholar
  46. 46.
    Scragg R, Stewart AW, Waayer D et al (2017) Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial. JAMA Cardiol.  https://doi.org/10.1001/jamacardio.2017.0175 Google Scholar
  47. 47.
    Jiang W-L, Gu H-B, Zhang Y-F et al (2015) Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol.  https://doi.org/10.1002/clc.22473 Google Scholar
  48. 48.
    Ford JA, MacLennan GS, Avenell A et al (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr.  https://doi.org/10.3945/ajcn.113.082602 Google Scholar
  49. 49.
    Schroten NF, Ruifrok WPT, Kleijn L et al (2013) Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J.  https://doi.org/10.1016/j.ahj.2013.05.009 Google Scholar
  50. 50.
    Dalbeni A, Scaturro G, Degan M et al (2014) Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis 24:861–868.  https://doi.org/10.1016/j.numecd.2014.02.015 CrossRefGoogle Scholar
  51. 51.
    Shedeed SA (2012) Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol 33:713–719.  https://doi.org/10.1007/s00246-012-0199-6 CrossRefGoogle Scholar
  52. 52.
    Witte KK, Byrom R, Gierula J et al (2016) Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol.  https://doi.org/10.1016/j.jacc.2016.03.508 Google Scholar
  53. 53.
    Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG (2015) No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Int J Epidemiol.  https://doi.org/10.1093/ije/dyv078 Google Scholar
  54. 54.
    Manousaki D, Mokry LE, Ross S et al (2016) Mendelian randomization studies do not support a role for vitamin d in coronary artery disease. Circ Cardiovasc Genet.  https://doi.org/10.1161/CIRCGENETICS.116.001396 Google Scholar
  55. 55.
    Vimaleswaran KS, Cavadino A, Berry DJ et al (2014) Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol.  https://doi.org/10.1016/S2213-8587(14)70113-5 Google Scholar
  56. 56.
    Ooi EM, Afzal S, Nordestgaard BG (2014) Elevated remnant cholesterol in 25-hydroxyvitamin D deficiency in the general population mendelian randomization study. Circ Cardiovasc Genet.  https://doi.org/10.1161/CIRCGENETICS.113.000416 Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2019

Authors and Affiliations

  1. 1.Department of PathologyUniversity of PisaPisaItaly
  2. 2.Department of Clinical and Experimental MedicineUniversity of PisaPisaItaly

Personalised recommendations